Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids

BACKGROUND: Targeted anti-HER2 therapy has greatly improved the prognosis for many breast cancer patients. However, treatment for HER2 negative disease is currently still selected from a multitude of untargeted chemotherapeutic treatment options. A predictive test was developed using patient-derived...

Descripción completa

Detalles Bibliográficos
Autores principales: Halfter, Kathrin, Hoffmann, Oliver, Ditsch, Nina, Ahne, Mareike, Arnold, Frank, Paepke, Stefan, Grab, Dieter, Bauerfeind, Ingo, Mayer, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855689/
https://www.ncbi.nlm.nih.gov/pubmed/27142386
http://dx.doi.org/10.1186/s12967-016-0855-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855689/
https://www.ncbi.nlm.nih.gov/pubmed/27142386
http://dx.doi.org/10.1186/s12967-016-0855-3

Ejemplares similares